|
Description:
|
This is a cross-disciplinary clinical course on HBV reactivation featuring speakers and panelists from the American Academy of Dermatology (AAD), American Society of Clinical Oncology (ASCO), American College of Rheumatology (ACR), and National Cancer Institute (NCI).
Goals and Objectives
-To assess the current frequency, course and outcome and management of reactivation of hepatitis B due to cancer chemotherapy and immunosuppressive treatment in the United States
-To develop resources and management algorithms and directions for future research in HBV reactivation.
|
|